We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Anti-allergic effect of 5,7-dihydroxy-4-methylcoumarin in IgE-mediated RBL-2H3 cells and PCA murine model.
- Authors
Gwon, Sugeun; Shin, Seong-Ah; Kim, Moonsu; Moon, Sun Young; Choi, Seyeon; Kim, Minji; Lee, Jun Hyuck; Park, Hyun Ho; Lee, Chang Sup
- Abstract
Allergy is an immune-mediated disorder characterized by an exaggerated response of the immune system to non-hazardous substances, resulting in allergic symptoms such as rash, itching, and runny nose. Current therapeutic interventions include antihistamines and steroids; however, they induce several side effects. Although 5,7-dihydroxy-4-methylcoumarin, a phytochemical derivative, has been demonstrated to exhibit antioxidant, anti-apoptotic, and anti-aggregatory effects, its anti-allergic properties and underlying molecular mechanisms remain elusive. Therefore, this study was conducted to investigate the anti-allergic effects of 5,7-dihydroxy-4-methylcoumarin in two experimental models: rat basophilic leukemia-2H3 cells sensitized using dinitrophenyl-specific immunoglobulin E (IgE)/human serum albumin and a passive cutaneous anaphylaxis (PCA) murine model. Our findings demonstrated that 5,7-dihydroxy-4-methylcoumarin reduced the release of histamine and β-hexosaminidase and downregulated the mRNA expression of allergic-inflammatory cytokines, such as interleukin (IL)-4, IL-13, and tumor necrosis factor-alpha, as well as the inflammatory enzyme cyclooxygenase-2. Furthermore, 5,7-dihydroxy-4-methylcoumarin reduced the phosphorylation of mitogen-activated protein kinases such as extracellular signal-regulated kinase and p38, as well as protein kinase B. In vivo, 5,7-dihydroxy-4-methylcoumarin reduced PCA reaction, as evidenced by reduced Evans blue dye extravasation in IgE-mediated local allergic responses. Collectively, these results suggest that 5,7-dihydroxy-4-methylcoumarin holds promise as a novel candidate for the development of anti-allergic drugs.
- Subjects
MITOGEN-activated protein kinases; EXTRACELLULAR signal-regulated kinases; TUMOR necrosis factors; IMMUNOGLOBULIN E; MEDICAL sciences; ANTIALLERGIC agents
- Publication
Applied Biological Chemistry, 2025, Vol 68, Issue 1, p1
- ISSN
2468-0834
- Publication type
Academic Journal
- DOI
10.1186/s13765-025-00980-4